Insiders trading at Akari Therapeutics Plc

Over the last 8 years, insiders at Akari Therapeutics Plc have traded over $0 worth of Akari Therapeutics Plc stock and bought 1,055,600 units worth $200,564 . The most active insiders traders include Mark S Cohen, Dov Elefant, and Donald Allen Williams. On average, Akari Therapeutics Plc executives and independent directors trade stock every 0 days with the average trade being worth of $2,406,768. The most recent stock trade was executed by Mark S Cohen on 18 September 2015, trading 1,055,600 units of AKTX stock currently worth $200,564.